Prot #CFOR258D2416: A 26 week, Randomized, Active-Controlled Safety Study of Double-Blind Formoterol Fumarate in Free Combination with an Inhaled Corticosteroid Versus an Inhaled Corticosteroid in Adolescent and Adult Patients with Persistent Asthma

  • Avila, Pedro C (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date5/20/14 → 4/30/19

Funding

  • Novartis Pharmaceuticals Corporation (CFOR258D2416)